Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

73.00
-0.1200-0.16%
Post-market: 73.000.00000.00%19:30 EDT
Volume:172.67K
Turnover:12.64M
Market Cap:3.75B
PE:22.46
High:74.15
Open:73.24
Low:72.37
Close:73.12
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:0.48
T/O Rate:0.62%
Dividend:2.58
Dividend Rate:3.53%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:6.37
PE(LYR):24.58

Loading ...

Cohen & Steers Q2 FY26 Adjusted EPS Rises 16.44% to $0.85; AUM Increases 7.5% to $100.1 Billion

Reuters
·
Jul 17

Cohen & Steers Q2 FY26 Diluted EPS Rises 15.85% to $0.95; Revenue Increases 4.88% to $152.7 Million

Reuters
·
Jul 17

U.S. Earnings Preview: After Market Close July 16

Dow Jones
·
Jul 17

Cohen & Steers RQI Fund Expects to Issue 12,642,989 Shares in Rights Offering Priced at $12.15 Each

Reuters
·
Jul 16

Cohen & Steers Quality Income Realty Fund, Inc. Announces Preliminary Results of Transferable Rights Offering

THOMSON REUTERS
·
Jul 16

Top News Today: Megacap Tech Names Lift U.S. Stock Indexes

Dow Jones
·
Jul 16

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

GlobeNewswire
·
Jul 15

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

GlobeNewswire
·
Jul 15

Is Axsome Therapeutics (AXSM) Reframing Its CNS Strategy With Pediatric Solriamfetol Trial Expansion?

Simply Wall St.
·
Jul 14

Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD

GlobeNewswire
·
Jul 14

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

GlobeNewswire
·
Jul 14

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

GlobeNewswire
·
Jul 13

Solvonis Wins U.S. Research Coverage as AUD Pipeline Targets Large CNS Market

TIPRANKS
·
Jul 13

Insilico Medicine Deepens CNS Drug Development Tie-Up With China Medical System

TIPRANKS
·
Jul 13

Cohen & Steers Crosses CAREIT Threshold, LC Capital Adds to PC Partner

sgx.com
·
Jul 13

Cohen & Steers is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 11

Cohen & Steers price target raised to $84 from $82 at Evercore ISI

TIPRANKS
·
Jul 10

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Jul 10

Cohen & Steers Assets Under Management Rise to $100.1 Billion at End-june 2026

Reuters
·
Jul 10